Integrative bioinformatics and machine learning approaches reveal oxidative stress and glucose metabolism related genes as therapeutic targets and drug candidates in Alzheimer’s disease
BackgroundAlzheimer’s disease (AD), the most common form of dementia, has treatments that slow but do not stop cognitive decline. Additional treatments are based on its pathogenic mechanisms are needed. Evidence has long highlighted oxidative stress and impaired glucose metabolism as crucial factors...
Saved in:
| Main Authors: | Fatima Noor, Sidra Aslam, Ignazio S. Piras, Cecilia Tremblay, Thomas G. Beach, Geidy E. Serrano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1572468/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioinformatics and experimental validation identify biomarkers for diagnosing Alzheimer’s disease
by: Hui Liu, et al.
Published: (2025-08-01) -
Generative artificial intelligence, integrative bioinformatics, and single-cell analysis reveal Alzheimer’s genetic and immune landscape
by: Arpita Das, et al.
Published: (2025-06-01) -
Relationship of fasting glucose and longitudinal Alzheimer's disease imaging markers
by: Robyn A. Honea, et al.
Published: (2022-01-01) -
Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
by: Elisa Gascón, et al.
Published: (2024-12-01) -
Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics
by: Pengpeng Liang, et al.
Published: (2025-04-01)